Zydus Lifesciences Incorporates US Wholly Owned Subsidiary

Zydus Lifesciences incorporated a new wholly owned subsidiary, Zara Merger SUB Inc., in the US on April 24, 2026.
The subsidiary is authorized to issue 1,000 common shares and was established for internal group restructuring purposes.
Zydus subscribed to 100% of the subsidiary's paid-up share capital with a cash consideration.